CONSOLIDATION

Clinical trials for CONSOLIDATION explained in plain language.

Never miss a new study

Get alerted when new CONSOLIDATION trials appear

Sign up with your email to follow new studies for CONSOLIDATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1 Terminated 3

New drug aims to lock in remission for rare lymphoma

Disease control Not yet recruiting

This study tests whether the drug elranatamab can help keep plasmablastic lymphoma, a rare and aggressive blood cancer, from returning after initial chemotherapy. About 17 adults with or without HIV who have already responded to first treatment will receive elranatamab injections…

Matched conditions: CONSOLIDATION

Phase: PHASE2, PHASE3 • Sponsor: University of Illinois at Chicago • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

CONSOLIDATION

Get alerted when new CONSOLIDATION trials appear

New drug aims to lock in remission for rare lymphoma